Regeneron Symbol - Search News

Order byBest matchMost fresh

23andMe, Regeneron and Biotechnology

23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private

Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe Hold...

· 10h

23andMe, Inc.: Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale

· 11h

Biotechnology Company Regeneron Buying 23andMe for $256 Million

· 9h

Struggling DNA testing firm 23andMe to be bought for $256m

23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m (£192m).

· 10h

Biotechnology company Regeneron buying 23andMe for $256 million

· 11h

Bankrupt DNA testing company 23andMe to be bought by Regeneron

Seeking Alpha4d

REGN Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection ...

Nasdaq10d

Interesting REGN Put And Call Options For July 18th

Investors in Regeneron Pharmaceuticals, Inc. (Symbol: REGN) saw new options become available today, for the July 18th expiration. One of the key data points that goes into the price an option ...

Yahoo Finance20d

Why Regeneron (REGN) Stock Is Falling Today

Shares of biotech company Regeneron (NASDAQ:REGN) fell 9.6% in the morning session after the company reported weak first-quarter 2025 results. Its revenue missed significantly, and its EPS fell ...

Hosted on MSN27d

Regeneron to Report Q1 Earnings: What's in Store for the Stock?

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter 2025 results on April 29, 2025. The Zacks Consensus Estimate for revenues is pegged at $3.25 billion ...

Nasdaq11d

Interesting REGN Put And Call Options For June 27th

Investors in Regeneron Pharmaceuticals, Inc. (Symbol: REGN) saw new options become available today, for the June 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

Reuters28d

Regeneron to invest over $3 billion to boost US manufacturing

April 22 (Reuters) - Regeneron Pharmaceuticals (REGN.O), opens new tab said on Tuesday it has signed a deal worth more than $3 billion with contract drug developer Fujifilm Diosynth, potentially ...

Yahoo Finance4d

Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments

Amgen prevented Regeneron from competing on a level playing field and unfairly denied patients access to Praluent. This anticompetitive practice shut out an innovative therapy from the PCSK9 ...